Načítá se...
Increased Glutamine in Patients Undergoing Long-term Treatment for Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study at 3 T
IMPORTANCE: The N-methyl-d-aspartic acid receptor hypofunction model of schizophrenia predicts a paradoxical increase in synaptic glutamate release. In vivo measurement of glutamatergic neurotransmission in humans is challenging, but glutamine, the principal metabolite of synaptic glutamate, can be...
Uloženo v:
| Vydáno v: | JAMA Psychiatry |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185982/ https://ncbi.nlm.nih.gov/pubmed/24402128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2013.3939 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|